When was HistoIndex founded?

HistoIndex was founded in 2010 and raised its 1st funding round 3 years after it was founded.

Where is HistoIndex located?

HistoIndex is headquartered in Singapore, Singapore.

Which legal entities is HistoIndex associated with?

HistoIndex is associated with HISTOINDEX PTE. LTD..

How many employees does HistoIndex have?

As of Jul 01, 2024, the latest employee count at HistoIndex is 20.

Is HistoIndex a funded company?

HistoIndex is a funded company, having raised a total of $6.89M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 06, 2013.

When was the latest funding round of HistoIndex?

HistoIndex's latest funding was a $***** Series A round on May 01, 2025, with participation from 3 investors.

Where does HistoIndex rank among its competitors?

HistoIndex ranks 16th amongst 281 active competitors, of which 86 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of HistoIndex?

HistoIndex's top competitors include PAIGE, PathAI and Deciphex. Among them, Techcyte secured the most recent funding round in April, 2026.

HistoIndex - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of AI powered digital pathology platform for fibrosis analysis. The platform utilizes Second Harmonic Generation (SHG) and Two-Photon Excitation (TPE) microscopy to capture high-resolution images of unstained tissue samples to quantify fibrosis and other morphological features. The technology accelerates therapeutic development and clinical trial by providing translatable data from preclinical studies to clinical trials and enhancing clinical diagnostics. It supports advancements and regulatory approvals across the drug development and clinical diagnostic value chain.

Website: histoindex.com
Social

Key Metrics

Founded Year

2010

Location

Singapore, Singapore

Stage

Series A

Total Funding

$6.89M in 2 rounds

Latest Funding Round

Series A, May 01, 2025, $*****

Investors

OCBC & 3 more

Ranked

16^th among 281 active competitors

Employee Count

20 as on Jul 01, 2024

Similar Companies

OpenEvidence & 2620 more

View HistoIndex's full profile

HistoIndex is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
HISTOINDEX PTE. LTD. CIN: 201009063Z , Singapore, Active	Dec 31, 2009	-	-

HistoIndex has raised a total funding of $6.89M over 2 rounds. Its first funding round was on Jun 06, 2013. Its latest funding round was a Series A round on May 01, 2025 for $*****. 3 investors participated in its latest round. HistoIndex has 4 institutional investors.

Here is the list of recent funding rounds of HistoIndex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2025	5974245	Series A	2688104	9037680	2129310	9447454
Jun 06, 2013	5205402	Seed	8635947	5841861	1718751	LBIC

Access funding benchmarks and valuations. Sign up today!

View details of HistoIndex's funding rounds and investors

The founders of HistoIndex are Gideon Ho and Dean Tai.

Here are the details of HistoIndex's key team members:

Gideon Ho: Co-Founder & CEO & Chief Commercial Officer of HistoIndex.
Dean Tai: Co-Founder & Chief Scientific Officer of HistoIndex.

HistoIndex's Board of Directors

HistoIndex's board has 5 active members. Chi Shang Tai, David John Jeans and Gideon Ho are part of team and Sim Giok Lak and Sim Kok Hwee are independent board members.

Here is the list of HistoIndex's board of directors:

Name	Type	Representing	Status	Duration
Chi Shang Tai	Team	-	Current	16y 2m
Gideon Ho	Team	-	Current	16y 2m
pqfzrmx	Team	-	Current	5y 5m
dy{hbv{	Team	-	Past	1y 2m
jbtetae	Team	-	Past	8y 8m
Sim Giok Lak	Independent board member	-	Current	15y 2m
alkxqor	Independent board member	-	Current	8y 4m
jf{vxsb	Independent board member	-	Past	6y 4m
l{coagf	Independent board member	-	Past	1y 8m

View details of HistoIndex's Founder profiles and Board Members

HistoIndex's employee count trend

HistoIndex has 20 employees as of Jul 24. Here is HistoIndex's employee count trend over the years:

Uncover HistoIndex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of HistoIndex include PAIGE, PathAI and Deciphex. Here is the list of Top 10 competitors of HistoIndex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	71/100
2nd	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Merck Global Health Innovation Fund ... & 22 others	71/100
3rd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
4th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Boehringer Ingelheim Venture Fund, Wellington Partners Venture Capital ... & 9 others	64/100
5th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
7th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	61/100
8th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	61/100
9th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
10th	Enspectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Tao Capital Partners & 6 others	59/100
16th	HistoIndex 2010, Singapore (Singapore), Series A	Provider of AI powered digital pathology platform for fibrosis analysis	$6.89M	ZIG Ventures, SEEDS Capital & 2 others	57/100